ES2092651T3 - Derivados heterociclicos diazotados n-sustituidos por un grupo bifenilmetilo, su preparacion, las composiciones farmaceuticas que los contienen. - Google Patents

Derivados heterociclicos diazotados n-sustituidos por un grupo bifenilmetilo, su preparacion, las composiciones farmaceuticas que los contienen.

Info

Publication number
ES2092651T3
ES2092651T3 ES92400523T ES92400523T ES2092651T3 ES 2092651 T3 ES2092651 T3 ES 2092651T3 ES 92400523 T ES92400523 T ES 92400523T ES 92400523 T ES92400523 T ES 92400523T ES 2092651 T3 ES2092651 T3 ES 2092651T3
Authority
ES
Spain
Prior art keywords
alkyl
group
substituted
phenylalkyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92400523T
Other languages
English (en)
Inventor
Claude Bernhart
Bernard Ferrari
Pierre Perreaut
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of ES2092651T3 publication Critical patent/ES2092651T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I): EN LA QUE NTAN CADA UNO INDEPENDIENTEMENTE HIDROGENO O UN GRUPO ELEGIDO ENTRE: . CO SUB 2 N = C (NH SUB 2) SUB 2, . CONHNHCONH SUB 2, . CONHNHCSNH SUB 2, . C(OC SUB 2 H SUB 5) = NCO SUB 2 CH SUB 3, . COCH SUB 2 CO SUB 2 H SUB 5, . COCH SUB 2 CO SUB 2 C SUB 2 H SUB 5, . N(OH)-CONHCOOC SUB 2 H SUB 5, . C(OC SUB 2 H SUB 5) = NH O UN HETEROCICLO NITROGENADO ELEGIDO ENTRE: CON LA CONDICION DE QUE AL MENOS UNO DE LOS SUSTITUYENTES R SUB 1 O R SUB 2 SEA DIFERENTE DEL HIDROGENO; UNO O VARIOS ATOMOS DE HALOGENO, UN ALCONILO EN C SUB 2-C SUB 6, UN CICLOALQUILO EN C SUB 3-C SUB 7, UN FENILO, UN FENILALQUILO EN EL QUE EL ALQUILO ESTA EN C SUB 1-C SUB 3, UN FENILALCENILO EN EL QUE EL ALCENILO ESTA EN C SUB 2-C SUB 3, ESTANDO DICHOS GRUPOS FENILOS NO SUSTITUIDOS O SUSTITUIDOS UNA O VARIAS VECES POR UN ATOMO DE HALOGENO, UN ALQUILO EN C SUB 1-C SUB 4, UN HALOGENOALQUILO EN C SUB 1-C SUB 4, UN POLIHALOGENOALQUILO EN C SUB 1-C SUB 4, UN HIDROXILO O UN ALCOXI EN C SUB 1-C SUB 4. UN ALQUILO EN C SUB 1-C SUB 6, UN CICLOALQUILO EN C SUB 3-C SUB 7, UN FENILO, UN FENILALQUILO EN EL QUE EL ALQUILO ESTA EN C SUB 1-C SUB 3, ESTANDO DICHOS GRUPOS ALQUILO, FENILO O FENILALQUILO NO SUSTITUIDOS O SUSTITUIDOS POR UNO O VARIOS ATOMOS DE HALOGENO O POR UN GRUPO ELEGIDO ENTRE UN PERFLUOROALQUILO EN C SUB 1-C SUB 4, UN HIDROXILO, UN ALCOXI EN C SUB 1 -C SUB 4. O R SUB 4 Y R SUB 5 UNIDOS JUNTOS REPRESENTAN, O UN GRUPO DE FORMULA (CH SUB 2) SUB N, O UN GRUPO DE FORMULA (CH SUB 2) SUB P Y (CH SUB 2) SUB Q, EN EL QUE Y ES, BIEN UN ATOMO DE OXIGENO, BIEN UN ATOMO DE AZUFRE, BIEN UN ATOMO CARBONO SUSTITUIDO POR UN GRUPO ALQUILO EN C SUB 1-C SUB 4, UN FENILO O UN FENILALQUILO EN EL QUE EL ALQUILO ESTA EN C SUB 1-C SUB 3, BIEN UN GRUPO N-R SUB 6 EN EL QUE R SUB 6 REPRESENTA UN HIDROGENO,UN ALQUILO EN C SUB 1-C SUB 4, UN FENILALQUILO EN EL QUE EL ALQUILO ESTA EN C SUB 1-C SUB 3; UN ALQUILCARBONILO EN C SUB 1-C SUB 4, UN HALOGENO-ALQUILCARBONILO EN C SUB 1-C SUB 4, UNPOLIHALOGENOALQUILCARBONILO EN C SUB 1-C SUB 4, UN BENZOILO, UN A-AMINOACILO O UN GRUPO N-PROTECTOR, O R SUB 4 Y R SUB 5 UNIDOS JUNTOS CON EL ATOMO CARBONO AL QUE ESTAN ENLAZADOS CONSTITUYEN UN INDANO O UN ADAMANTANO; IDO ENTRE 2 Y 11; Y 5; ESENTA 1; Y SUS SALES. APLICACION: ANTAGONISTAS DE LA ANGIOTENSINA II.
ES92400523T 1991-03-01 1992-02-28 Derivados heterociclicos diazotados n-sustituidos por un grupo bifenilmetilo, su preparacion, las composiciones farmaceuticas que los contienen. Expired - Lifetime ES2092651T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9102501A FR2673427B1 (fr) 1991-03-01 1991-03-01 Derives heterocycliques diazotes n-substitues par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.

Publications (1)

Publication Number Publication Date
ES2092651T3 true ES2092651T3 (es) 1996-12-01

Family

ID=9410261

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92400523T Expired - Lifetime ES2092651T3 (es) 1991-03-01 1992-02-28 Derivados heterociclicos diazotados n-sustituidos por un grupo bifenilmetilo, su preparacion, las composiciones farmaceuticas que los contienen.

Country Status (9)

Country Link
US (1) US5268375A (es)
EP (1) EP0501892B1 (es)
JP (1) JPH05132467A (es)
AT (1) ATE140698T1 (es)
DE (1) DE69212346T2 (es)
DK (1) DK0501892T3 (es)
ES (1) ES2092651T3 (es)
FR (1) FR2673427B1 (es)
GR (1) GR3021372T3 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470975A (en) * 1990-10-16 1995-11-28 E.R. Squibb & Sons, Inc. Dihydropyrimidine derivatives
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
GR1001386B (el) * 1991-12-24 1993-10-29 Takeda Chemical Industries Ltd Ετεροκυκλικές ενώσεις.
US5654322A (en) * 1992-08-11 1997-08-05 Wakunaga Seiyaku Kabushiki Kaisha Biphenylmethane derivatives and pharmaceuticals containing the same
CA2141792A1 (en) * 1992-08-11 1994-02-12 Terukage Hirata Biphenylmethane derivatives and pharmaceuticals containing the same
JPH06239859A (ja) * 1992-09-14 1994-08-30 Takeda Chem Ind Ltd アンギオテンシンｉｉ拮抗作用を有する環状化合物およびその用途
ATE167861T1 (de) * 1992-09-14 1998-07-15 Takeda Chemical Industries Ltd 1,2,4-oxadiazolyl oder 1,2,4-thiadiazolyl- derivate als angiotensin ii antagonisten
GB9223371D0 (en) * 1992-11-06 1992-12-23 Ici Plc Heterocyclic compounds
ATE204276T1 (de) * 1992-12-22 2001-09-15 Takeda Chemical Industries Ltd Heterocyclische verbindungen mit angiotensin-ii- antagonistischer wirkung und ihre anwendung
JP3412887B2 (ja) * 1992-12-22 2003-06-03 武田薬品工業株式会社 アンギオテンシンｉｉ拮抗作用を有する複素環化合物およびその用途
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
CA2125251C (en) * 1993-06-07 2005-04-26 Yoshiyuki Inada A pharmaceutical composition for angiotensin ii-mediated diseases
JP3057471B2 (ja) 1993-06-07 2000-06-26 武田薬品工業株式会社 アンジオテンシンｉｉ介在性諸疾患の予防または治療剤
US5468762A (en) * 1994-05-18 1995-11-21 American Home Products Corporation Azolidinediones as antihyperglycemic agents
US6162922A (en) * 1998-01-30 2000-12-19 Bristol-Myers Squibb Co. Method for preparing N-substituted heterocyclic derivatives using a phase-transfer catalyst
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
US8778963B2 (en) * 2003-11-25 2014-07-15 3M Innovative Properties Company Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
ATE493973T1 (de) 2004-06-04 2011-01-15 Teva Pharma Irbesartan enthaltende pharmazeutische zusammensetzung
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3239170B1 (en) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
CZ2015687A3 (cs) 2015-10-02 2017-04-12 Zentiva, K.S. Farmaceutická kompozice obsahující kombinaci kandesartanu, amlodipinu a hydrochlorthiazidu

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675403A (en) * 1985-10-16 1987-06-23 American Home Products Corporation 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity
US4916129A (en) * 1989-01-19 1990-04-10 E. I. Du Pont De Nemours And Company Combination β-blocking/angiotensin II blocking antihypertensives
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
CA2020073A1 (en) * 1989-07-03 1991-01-04 Eric E. Allen Substituted quinazolinones as angiotensin ii antagonists
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
US5100897A (en) * 1989-08-28 1992-03-31 Merck & Co., Inc. Substituted pyrimidinones as angiotensin ii antagonists
NZ237476A (en) * 1990-03-20 1994-01-26 Sanofi Sa N-substituted heterocyclic compounds and pharmaceutical compositions.
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof

Also Published As

Publication number Publication date
ATE140698T1 (de) 1996-08-15
DK0501892T3 (da) 1996-11-25
FR2673427B1 (fr) 1993-06-18
JPH05132467A (ja) 1993-05-28
DE69212346T2 (de) 1997-02-20
FR2673427A1 (fr) 1992-09-04
EP0501892A1 (fr) 1992-09-02
US5268375A (en) 1993-12-07
GR3021372T3 (en) 1997-01-31
EP0501892B1 (fr) 1996-07-24
DE69212346D1 (de) 1996-08-29

Similar Documents

Publication Publication Date Title
ES2092651T3 (es) Derivados heterociclicos diazotados n-sustituidos por un grupo bifenilmetilo, su preparacion, las composiciones farmaceuticas que los contienen.
AR040031A1 (es) Compuestos de pirazol-pirimidina anilina utiles como inhibidores de cinasa y composiciones farmaceuticas que los contienen
DE68924456T2 (de) Mittel zur Verbesserung von Arzneimitteleffekten für Antitumormittel.
MX9303770A (es) Derivados de alquilamino ramificados de tiazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ATE130610T1 (de) 3-ureido-benzodiazepinone verwendbar als cck- oder gastrin-antagonisten.
ATE128463T1 (de) Piperidin und pyrrolidin derivate.
ATE168672T1 (de) Indol-piperazin-derivate als selektive liganden der 5ht1d und 5ht1b receptoren verwendbar als arzneimittel
ES8307244A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzamida.
DK1471059T3 (da) 2,4,6-tris(dineopentyl-4'-aminobenzalmalonat)-s-triazin, fotobeskyttende kosmetiske sammensætninger indeholdende denne forbindelse og anvendelse af den nævnte forbindelse
RU2004130284A (ru) Антипаразитарные производные артемизинина (эндопероксиды)
YU43902A (sh) Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
ES545310A0 (es) Procedimiento para la preparacion de un nuevo derivado de lafenil-3-propeno-2 amina
NO166321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinforbindelser.
ATE109475T1 (de) Benzothiazolinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DK0419360T3 (da) Phenothiazinderivater, deres fremstilling og farmaceutiske præparater indeholdende disse

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 501892

Country of ref document: ES